期刊文献+

中药穴位贴敷对慢性阻塞性肺疾病稳定期患者临床观察及免疫功能的影响 被引量:5

下载PDF
导出
摘要 目的:观察中药穴位贴敷对慢性阻塞性肺疾病稳定期患者临床观察及免疫功能的影响。方法:选取90例慢性阻塞性肺疾病患者,三伏天采用针灸、拔罐、中药穴位敷贴治疗,每年一疗程10次,观察两组治疗前后细胞免疫(CD4+、CD8+、CD4+/CD8+)的变化。结果:两组治疗前与治疗后比较,均P<0.05差异具有统计学意义,表明经治疗后患者整体免疫功能有提升,治疗有效。结论:三伏天采用针灸、拔罐、中医穴位敷贴对改善慢性阻塞性肺疾病稳定期患者的免疫功能疗效确切,能减少慢阻肺复发,值得临床推广应用。 objective:to observe the effect of Chinese traditional Chinese medicine acupuncture on the clinical observation and immune function of patients with chronic obstructive pulmonary disease.Methods:choose 90 cases of patients with chronic obstructive pulmonary disease,the dog days using acupuncture,cupping therapy,Chinese medicine acupoint sticking therapy,treatment 10 times a year,observed two groups before and after treatment the immune cells(CD4+,CD8+,CD4+/CD8+)changes.Results:before and after treatment,the difference of P<0.05 was statistically significant,indicating that the overall immune function of patients after treatment was improved and the treatment was effective.Conclusion:the dog days using acupuncture,cupping therapy,Chinese medicine acupoint sticking to improve immune function in patients with chronic obstructive pulmonary disease stabilization curative effect,can reduce the recurrence of copd,worthy of clinical popularization and application.
出处 《湖南中医药大学学报》 CAS 2018年第A01期341-341,共1页 Journal of Hunan University of Chinese Medicine
基金 浦东新区已病防变慢阻肺特色专病资助(项目编号:PDZYX-2-2014002)。
关键词 慢性阻塞性肺疾病 缓解期 穴住敷贴 T细胞亚群 chronic obstructive pulmonary disease Remission To hold the application T cell subgroups
  • 相关文献

参考文献3

二级参考文献15

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1789
  • 4Pilette C,Ouadrhiri Y,Godding V,et al.Lung mucosal immunity:immunoglobulin-A revisited[J].Eur Respir J,2001,18(3):571-572.
  • 5Fujita J,Yamadori I,Suemitsu I,et al.Clinical features of non-specific interstitial pneumonia[J].Respir Med,1999,93(2):113-118.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
  • 8Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
  • 9Celli BR, Cote CG, Matin JM, et al. The body mass index,airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004,350 : 1005-1012.
  • 10食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:54.

共引文献1844

同被引文献59

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部